Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow-to-Debt Ratio
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of $360.04 Billion could theoretically repay 0% of its total liabilities ($7.77 Trillion) in one year. Explore Takeda Pharmaceutical Co Ltd ADR long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Takeda Pharmaceutical Co Ltd ADR Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. Also explore TAK total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Takeda Pharmaceutical Co Ltd ADR (2001–2025)
Year-by-year debt coverage analysis for Takeda Pharmaceutical Co Ltd ADR. For market capitalisation and broader financial context, see TAK stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $1.06 Trillion | $7.31 Trillion | ▲ +58.1% |
| 2024 | 0.09x | $716.34 Billion | $7.83 Trillion | ▼ -28.9% |
| 2023 | 0.13x | $977.16 Billion | $7.60 Trillion | ▼ -14.2% |
| 2022 | 0.15x | $1.12 Trillion | $7.49 Trillion | ▲ +14.7% |
| 2021 | 0.13x | $1.01 Trillion | $7.74 Trillion | ▲ +57.9% |
| 2020 | 0.08x | $669.75 Billion | $8.09 Trillion | ▲ +119.4% |
| 2019 | 0.04x | $328.48 Billion | $8.71 Trillion | ▼ -79.1% |
| 2018 | 0.18x | $377.85 Billion | $2.09 Trillion | ▲ +66.6% |
| 2017 | 0.11x | $261.36 Billion | $2.41 Trillion | ▲ +672.3% |
| 2016 | 0.01x | $25.49 Billion | $1.81 Trillion | ▼ -83.9% |
| 2015 | 0.09x | $182.52 Billion | $2.09 Trillion | ▲ +19.4% |
| 2014 | 0.07x | $148.34 Billion | $2.03 Trillion | ▼ -58.8% |
| 2013 | 0.18x | $307.71 Billion | $1.73 Trillion | ▼ -20.6% |
| 2012 | 0.22x | $336.57 Billion | $1.51 Trillion | ▼ -55.6% |
| 2011 | 0.50x | $326.94 Billion | $649.75 Billion | ▼ -13.1% |
| 2010 | 0.58x | $381.17 Billion | $658.53 Billion | ▲ +25.3% |
| 2009 | 0.46x | $326.27 Billion | $706.35 Billion | ▼ -16.8% |
| 2008 | 0.56x | $292.50 Billion | $526.75 Billion | ▲ +62.2% |
| 2007 | 0.34x | $209.28 Billion | $611.38 Billion | ▼ -36.4% |
| 2006 | 0.54x | $373.57 Billion | $693.87 Billion | ▼ -0.9% |
| 2005 | 0.54x | $295.54 Billion | $544.02 Billion | ▼ -3.2% |
| 2004 | 0.56x | $311.12 Billion | $554.65 Billion | ▲ +4.7% |
| 2003 | 0.54x | $263.45 Billion | $491.64 Billion | ▲ +12.7% |
| 2002 | 0.48x | $240.59 Billion | $505.88 Billion | ▲ +11.3% |
| 2001 | 0.43x | $212.66 Billion | $497.69 Billion | — |